Latest Regulatory Approvals News

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

Radiopharm Theranostics has inked a clinical supply agreement with Cyclotek to support its Phase 1 trial of RAD 402, a novel radiotherapeutic targeting prostate cancer, set to commence in Australia in late 2025.

Rhythm Biosciences has regained NATA accreditation for its geneType laboratory, a key step toward commercialising its ColoSTAT® cancer risk test as an in-house diagnostic.

Capricorn Metals has extended its mining contract with MACA Ltd for Karlawinda and named MACA preferred contractor for Mt Gibson, locking in cost certainty and supporting production growth.

Garda Property Group has announced a quarterly distribution of AUD 0.018 per security, combining an ordinary and a special fully franked dividend, reflecting strong capital outcomes from FY24.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Alligator Energy has raised A$17.25 million through a strongly supported placement to institutional investors, positioning the company to advance key development stages at its Samphire Uranium Project. The funds will underpin exploration, feasibility studies, and the upcoming Field Recovery Trial.

Larvotto Resources has secured preliminary regulatory approval to extend mining at its Hillgrove Gold-Antimony Mine through 2026, paving the way for project financing and production ramp-up.

PointsBet Holdings Limited updates shareholders on competing takeover bids, endorsing MIXI’s $1.20 cash offer while highlighting significant uncertainties and lower value in Betr Entertainment’s all-scrip proposal.

Prominence Energy has agreed to acquire a vast natural hydrogen and helium exploration portfolio on the Gawler Craton, backed by a $1.75 million capital raise and strategic board appointments.

Optiscan Imaging Ltd has entered a five-year exclusive collaboration with Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein drug AK-FLOUR®, supporting US clinical trials and FDA regulatory submissions for Optiscan’s InVue® surgical device.

Magnetic Resources NL has announced a significant 22% increase in the Lady Julie Gold Project resource, now totaling 2.14 million ounces, boosting the overall Laverton region resource to 2.32 million ounces. This upgrade reflects enhanced confidence in mineral continuity and advances the project closer to development.